Adeia Inc. (ADEA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $26.50, Adeia Inc. (ADEA) is priced for +9.9% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/ADEA

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Solve inputs: computed at a 9% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.3%); the inversion above states its own rate.

Per-Model Detail (n=18)

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• Adeia manufactures nothing and sells nothing: it owns patents and licenses them, with media rights supplying 94% of revenue and semiconductor rights 6%, and its chip licensees include Kioxia, Micron, Samsung, SanDisk, SK Hynix, Sony.
• The single biggest risk is timing rather than demand, because a licensing renewal that slips a quarter takes its whole payment with it, a hazard the 10-K states plainly: The structure and timing of our IP license agreements may cause fluctuations in our quarterly or annual financial results.
• Second-quarter results are due August 3, 2026, the first real check on full-year revenue guidance of $395 million to $435 million.

Bull Case

Start with what the market is paying, because it is unusually explicit here. About 31 times a year of company-wide operating income, for a business with no factories, no inventory and no distribution. The 10-K puts the whole enterprise in nine words: We operate and report in one segment: IP Licensing. What the buyer is paying for is a legal position, and legal positions either hold or they don't.

The fundamentals say this one has been holding. Trailing operating margin runs 27.7%, which is what happens when the cost of serving an additional licensee is a signature. Chip licensees include Kioxia, Micron, Samsung, SanDisk, SK Hynix, Sony, under agreements that can include fixed fees, per-unit fees, production based fees, milestone based fees, or a combination of these fees covering products from mobile phones, laptops, PCs, game consoles and servers. That is not a niche royalty on one chip line. It is a toll on a broad slice of consumer electronics, collected in several different shapes so no single pricing mechanism carries the business.

Cash has gone where a leveraged licensor's cash should go. The 10-K records that in 2025 the company made $60.4 million in principal payments, bringing the outstanding balance to $426.7 million as of December 31, 2025 and repurchased $20.0 million of our common stock in 2025. Debt down first, shares second, in that order. Interest is covered 2.6 times by operating income, and net debt sits at 2.73 times operating income on a pre-tax basis. Neither figure is comfortable in the way a cash-rich software company's is, but the direction of travel has been consistent and the term loan was in full compliance with its covenants at the end of 2025.

The second half of the bull thesis is the portfolio widening beyond where it started. New licensees signed in the first quarter of 2026 included AMD and Microsoft, and in early second quarter a multi-year media license with L'Oréal, a cosmetics company using the media portfolio in e-commerce. A patent estate that started in television guides now gets paid by a chipmaker, a software platform and a beauty brand. Each new counterparty of that kind matters twice: it adds revenue, and it demonstrates the patents read on more industries than the market's pay-TV mental model assumes.

For scale, Rambus (RMBS) runs the closest comparable model and shows what the ceiling looks like: $721 million of trailing revenue growing 19.1%, operating margins of 35.9% and gross margins of 79.5%, though part of that comes from an actual product line, since its revenue consists of product, royalties and contract and other revenue. Adeia is a purer licensing play at roughly half the size, which cuts both ways, but the peer establishes that a licensor of this shape can carry higher margins at greater scale rather than watching them erode.

The valuation case follows from all of it. Only the methods that credit forward growth reach today's price; the ones that value the business off its book or a single year of earnings land at less than half of it. That is the standard signature of a business whose value sits in a durable intangible position rather than in assets you can count. Management has raised its own guidance four times since 2020 and reaffirmed it on two further occasions, which is how a team behaves when it sets numbers it expects to make.

Bear Case

A patent licensor's revenue is a sequence of negotiations that happen to close inside calendar quarters. Nothing about the underlying value of the patents changes when a renewal slips from June to July, but everything about the reported quarter does. The 10-K does not hide this: The structure and timing of our IP license agreements may cause fluctuations in our quarterly or annual financial results. That is the first thing to understand about the fundamentals here, and it is why a smooth-looking multiple sits on top of a lumpy business.

The second thing is that the counterparties are large and the company is not. Licensees negotiate together, and the filing acknowledges what that produces: agreements with terms that differ in some respects from those contained in other agreements that may obligate us to provide different, more favorable, terms to those customers, which could, if applied, result in lower revenue. A concession granted to one licensee can travel. Verification is no easier, since audits of licensee reporting are expensive, time consuming, potentially detrimental to our ongoing business relationships with our customers and, in some cases, may not be cost justified. The revenue line depends partly on counterparties reporting their own volumes honestly, and checking is costly enough that it is not always done.

Rambus, running the same model, names the structural endgame in its own risk factors: for those license agreements that convert to fully paid-up licenses, our results of operations following such conversion could be adversely affected. A patent licensor can sign a large deal that looks like a triumph and quietly retire a future revenue stream in the process. That is not a hypothetical failure mode; it is the standard arc of the asset class.

Now the disconnect. The market is paying about 31 times a year of company-wide operating income, which prices today's economics carried forward roughly 5.6 years. The multiple sits at the very top of its peer distribution, and of comparable fast-growing companies historically, only about 28% held that pace for a stretch that long. To defend the price on margins rather than duration, operating margins would need to reach around 36.6% against roughly 27.7% today. Neither version of the requirement is impossible. Both are demanding for a business whose patents age on a fixed schedule and whose largest customers renegotiate on theirs.

The lenses split accordingly. Only the methods that project growth forward reach the current price. Value the company on its book, on a single year of earnings power, or on what peers fetch per dollar of sales, and the answer comes in at less than half of today's quote. That gap is the durability premium in plain sight: the market is paying for the patent estate to keep generating for years, and every static method is structurally unable to credit that. Fair enough. But it means there is no valuation floor underneath the price, only a judgment about persistence.

The balance sheet narrows the room for error. The 10-K discloses that As of December 31, 2025, we had $426.7 million of total debt outstanding under our Term Loan B, a facility that matures in June 2028, and interest is covered 2.6 times by operating income with net debt at 2.73 times operating income before tax. That is manageable in a business collecting royalties on schedule. It is less manageable through a year in which two large renewals land late. And for all the deleveraging, the share count still grew about 2% a year over the four years to March 2026, so the $20 million of stock repurchased in 2025 did not offset what was issued.

The concession is real: this is a cash-generative business with respectable margins and a widening licensee list, and nothing in the filings suggests distress. The bear case is not about the company breaking. It is that a price built on a five-year-plus persistence assumption leaves nothing for the ordinary lumpiness the company itself warns about.

Valuation

What today's price assumes is less a growth rate than a calendar. At $25.95 the market is paying about 31 times a year of company-wide operating income, and that works out to today's economics carried forward roughly 5.6 years before anything is allowed to fade. Read the same price through margins instead and it asks for operating margins near 36.6% against the 27.7% the business earns today. Two ways of saying one thing: the price wants either more profit per dollar of licensing, or a longer run at the current rate.

How often that run has been achieved is the useful context. Among comparable fast-growing companies, only about 28% sustained the pace for a stretch of that length, and the multiple itself sits at the very top of the peer distribution rather than anywhere near its middle. Neither statistic forecasts anything. Together they say the price is at the demanding end of what businesses of this shape have historically delivered.

The methods split cleanly and the split is informative. Only the approaches that project cash flows forward with growth land above the current price. Value the company on its book value, on a single year of normalized earnings power, or against what peers fetch per dollar of revenue, and every one of them comes in at less than half of today's quote. For an asset-light licensor this is close to structural: the balance sheet holds patents carried at amortized cost rather than at what they earn, so a book-based method is measuring the wrong thing almost by construction. The earnings-power version is more pointed, because it capitalizes a normalized year of operating profit with no growth at all and still lands far below. The whole premium, on that reading, is duration.

Rambus (RMBS) supplies the peer anchor at $721 million of trailing revenue growing 19.1%, with operating margins of 35.9% and gross margins of 79.5%. It is the closest listed analogue and it is meaningfully larger, though its mix includes an actual product line alongside royalties. The comparison cuts in the bull's favor on the margin question, since it shows a licensor of this type sustaining higher profitability at greater scale, and against it on the multiple, since Adeia's is the more expensive of the two positions relative to what each business currently earns.

Solvency is the piece that limits how long a bad patch can run. Interest is covered 2.6 times, and net debt of $275.5 million works out to 2.73 times operating income before tax. On hand at the latest count sits $115.8 million of liquid assets, and the 10-K records that during 2025 the company made $60.4 million in principal payments, bringing the outstanding balance to $426.7 million as of December 31, 2025. The term loan runs to June 2028, so there is room. It is not the kind of room that lets a licensor wait out two years of stalled renewals without the equity noticing.

The share count is the quiet detail. It has grown about 2% a year over the four years to March 2026 despite $20.0 million of buyback in 2025, so the per-share arithmetic starts each year slightly behind the company arithmetic. Small, steady, and worth carrying in any five-year projection of what the price already assumes.

Catalysts

First-quarter results, announced May 4, 2026, delivered $105 million of revenue and $58 million of operating cash flow. More consequential than the numbers were the signatures behind them. Adeia added AMD and Microsoft as licensees during the quarter, and in early second quarter signed a multi-year media license with L'Oréal for use in e-commerce. For a licensor whose reputation is anchored to television, a chipmaker, a software platform and a cosmetics group inside two quarters is a meaningful widening of the customer base.

The full-year frame is revenue guidance of $395 million to $435 million for 2026, with management describing the first and second halves as contributing roughly equally. Management's own outlook also has pay-TV falling to between 35% and 40% of revenue, which is the transition the whole thesis rests on: the legacy media business shrinking as a share while newer licensing categories grow into the gap. The direction is right and the timing is the open question.

Second-quarter results are scheduled for August 3, 2026, with a call the same afternoon. Two things in that release carry the information. The first is the revenue split between recurring royalties and one-time catch-up payments for prior use, since the latter flatters a quarter without extending the run rate. The second is whether any large renewal has moved, because in this business a schedule change and an earnings miss are frequently the same event.

Peer Cohorts (Per Segment, With Filing Citations)

IP Licensing (reported)

• RMBS (RAMBUS INC)
• FY2025 10-K: …from existing or potential customers, as any litigation opponents may attempt to use such proceedings to delay or otherwise impair any pending cases and our existing or potential customers may await the final outcome of any proceedings before agreeing to new licenses or to paying royalties. 30 Table of Contents…
• FY2025 10-K: …others may seek to use our technology without the payment of license fees and royalties, which could weaken our competitive position, reduce our operating results and increase the likelihood of costly litigation. The growth of our business depends in part on the use of our IP in the products of third parties and our…
• PSKY (Paramount Skydance Corporation)
• FY2025 10-K: …For affiliate revenues, payments are generally due monthly. Subscription revenues to our streaming services are recognized evenly over the subscription period. Theatrical Revenues -Theatrical revenue is earned from the theatrical distribution of our films during the exhibition period. Under these arrangements,…
• FY2025 10-K: …rating or impressions delivered to the total guaranteed in the contract. To the extent the amounts billed exceed the amount of revenue recognized, such excess is deferred until the guaranteed audience ratings or impressions are delivered. Affiliate Revenues -The performance obligation for our affiliate agreements is…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.